Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2. Dutta R, Zhang TY, Kohnke T, Thomas D, et al. J Clin Invest 2020;130:1843-1849.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dutta R, Zhang TY, Kohnke T, Thomas D, et al. Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2. J Clin Invest 2020;130:1843-1849.
PMID: 31895700